PTK2 and neoplasm: Indeed, inhibiting FAK kinase activity in murine models of breast and pancreatic cancer reduced tumour growth and limited CD45+ immune cells [27] and TAM infiltration [21,22,28], indicating a tumour-promoting FAK function.